EPO Patent Bulletin: Glycolysis Inhibitors Boost Neural Stem Cells

ChangeBridge: EPO Bulletin - Biotech (C12N)

Published March 18th, 2026

Detected March 24th, 2026

Summary

The European Patent Office (EPO) has published a patent application detailing the use of glycolysis-inhibiting compounds to enhance neural stem cell function. The application, EP2026030225A1, was published on March 18, 2026, and covers various European designated states.

View original document View source feed page

What changed

The European Patent Office (EPO) has published patent application EP2026030225A1, which describes a method for boosting neural stem cell function in the brain using glycolysis-inhibiting compounds. The publication date is March 18, 2026, and it includes IPC classifications related to medicinal preparations, nervous system disorders, and cell culture.

This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. It is primarily of interest to companies and researchers in the biotechnology and pharmaceutical sectors involved in neural stem cell research and therapeutic development. The application is designated for several European states, indicating potential future commercial interest in these regions.

Source document (simplified)

← EPO Patent Bulletin

USE OF GLYCOLYSIS-INHIBITING COMPOUNDS TO BOOST NEURAL STEM CELL FUNCTION IN THE BRAIN

Publication EP2026030225A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

A61K 35/30 20150101AFI20260207BHEP A61P 25/00 20060101ALI20260207BHEP C12N 5/074 20100101ALI20260207BHEP C12N 5/0793 20100101ALI20260207BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →